The Recall Desk
Agency classClass IOur severity:CriticalFDA (Devices)·Z-0307-2017·Announced 2016-11-16

FDA Recalls Pipeline Embolization Devices Due to Coating Delamination

Micro Therapeutics Inc is recalling Pipeline Embolization Devices because PTFE coating may delaminate and enter the bloodstream.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 5/5 (Critical).

Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The FDA classified this recall as Class I, which meets the rubric criteria for a Critical severity score.

Plain-English summary

Micro Therapeutics Inc, doing business as Ev3 Neurovascular, is recalling the Pipeline Embolization Device (Pipeline Classic). The recall involves 11,860 units distributed worldwide, including nationwide in the United States and internationally to numerous countries.

The recall was initiated because delamination and detachment of the PTFE (polytetrafluoroethylene) coating material may lead to PTFE coating entering the bloodstream. The device is indicated for the endovascular treatment of adults with large or giant widenecked intracranial aneurysms in the internal carotid artery.

The FDA has classified this recall as Class I, which is the most serious type of recall. Patients who have had this device implanted should contact their healthcare provider for guidance on monitoring and potential follow-up care.

The recalled product

Product
Pipeline Embolization Device (Pipeline Classic) The device is indicated for the endovascular treatment of adults (22 year of age or older) with large or giant widenecked intracranial aneurysms (lAs) in the internal carotid artery from the petrous to the superior hypophyseal…
Affected units
11,860

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 4 recalled by Micro Therapeutics Inc, Dba Ev3 Neurovascular under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Similar recalls